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Liver Transplantation in Black Recipients: Pittsburgh 
L. Teperman, V. Scantlebury, A. Tzakis, A. Staschak, S. Todo, and T.E. Starzl 
L IVER transplantation has been offered at the University 
of Pittsburgh since early 1981. The principal criterion 
for case selection when an organ becomes available is 
recipient medical urgency. In 1987, a point system was 
developed by us for the equitable distribution of extrarenal 
organs, and this was adopted by the United Network for 
Organ Sharing (UNOS).1.2 In addition to medical urgency, 
time waiting and proximity to the transplant center of both 
the donor and recipient contribute to the points accrued by a 
candidate. No credits or demerits are given for race, color, 
creed, national origin, or socioeconomic class. 
In this study, we examined the percentage of transplants 
performed by race as well as the outcomes in the ethnic 
subgroups. The broad categories of black and non black were 
used. The non black group was further subdivided into 
Caucasian, Hispanics, and Asians. We were particularly 
interested to see if the patterns of organ distribution were 
significantly different before and after the implementation of 
the point system in 1987. 
PATIENTS AND METHODS 
One thousand four hundred twenty-nine (1429) patients underwent 
1829 liver transplantations at the University of Pittsburgh between 
March 1981 and December 1988. Liver-kidney, liver-heart, liver-
pancreas, and multivisceral transplantations were not included. 
The donor and recipient had the same ABO blood type unless the 
urgency was so great that the patient could not wait. The incidence 
of ABO compatible but not identical donors or ABO incompatible 
donors3 was less than 10%. Postoperative immunosuppression was 
with cyclosporine and prednisone, to which azathioprine and OKT3 
were added variably as adjuncts. Actuarial patient and graft 
survivals were calculated. Statistical analysis was performed using 
BMDP software. Significance was assessed by the Mantle-Cox or 
the Breslow test. 
RESULTS 
Ethnic Representation 
Over the 8-year period, there were 1309 non black patients 
and 120 (8.4%) who were black (Table 1). Other minorities, 
which included Hispanic, Asians, and American Indians, 
accounted for 94 recipients (6.6%). Thus, the total represen-
tation of minorities was 15% (Table 1). 
The number of minority cases was not changed by the 
institution of the point system in early 1987. If anything, the 
Table 1. Ethnic Distribution in 1429 Liver Transplant 
Recipients, 1981-1988 
White 
Black 
Other minorities" 
1215 
120 
94 
"Hispanic, Asian, and American Indians. 
(85%) 
(8.4%) 
(6.6%) 
percentage of black recipients dropped off in 1987 and 1988 
compared to the highwater year of 1986 (Fig 1). 
Ethnicity and Survival 
Two-year survival curves are shown in Fig 2. Hispanic 
recipients did best, Asians fared worst, and black and white 
patients were in between. The results in black recipients were 
not significantly different at 2 years from those in the 
combined other groups (Fig 3). 
An Artifact of Age 
The mean age of the 120 black patients was 19.3 ± 16.4 (SD) 
years, compared to 31.9 ± 20.4 (SD) for the 1309 nonblack 
patients. This meant that there was a substantially higher 
proportion of black pediatric recipients, relative to the total 
black patient pool, in comparison to the white recipients. 
Therefore, it became necessary to analyze the pediatric and 
adult patient populations separately. 
The Average Adult Black Recipient 
The liver diseases for which treatment was undertaken were 
very similar among adult blacks and nonblacks (Table 2). 
However, black adults were underrepresented relative to the 
rest of the adult patients, both before and after the implemen-
titioILof the point system in early 1987. Throughout the 8 
years (1981-1988), blacks accounted for only 6.0% of the 
adults receiving transplants. Furthermore, the average age of 
the black patients was 33.95 ± 10.20 (SD) years vs 43.36 ± 
12.44 (SD) years for the nonblack group. 
Black women appeared to have a different incidence of 
disease requiring transplant. Thirty-eight of the 60 black 
adults were females. The diagnosis of primary biliary cirrho-
sis, a predominantly woman's disease was the reason for 
transplantation 207 times. Only 4 of these recipients were 
black. 
Survival for the small number of blacks who managed to 
get into the candidacy stream leading to eventual transplan-
tation was inferior to that of .non blacks (Fig 4). By the end of 
2 years, less than half. of the black recipients were alive 
compared to 70% of non blacks (p < 0.015). 
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Fig 1. Black and non black recipients by year from 1981 
through 1988. The point system was first used in 1987. 
The Average Pediatric Black Recipient 
Black infants and children had most of the same diseases as 
their non black counterparts (Table 3). They represented 
13.9% of the pediatric caseload, which was defined by an age 
ceiling of 18 years. The mean age of the black patients was 
5.21 ± 4.70 (SO) years vs 5.44 ± 4.62 (SO) for nonblacks. 
In contrast to the adults, the black pediatric recipients 
survived at a higher rate at all postoperative times than their 
non black companions (Fig 5). At 2 years, three-quarters of 
the blacks were alive vs two thirds of the nonblacks. These 
differences were not significant (p = 0.184). 
DISCUSSION 
This is the first report of the influence of race on liver 
candidacy and on posttransplantation survival. Overall, the 
black recipients did not do worse than the non black patients, 
an observation similar to that reported from our center with 
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Fig 2. Two-year patient survival of liver transplants by race, 
1981 through 1988. 
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Fi9 3. Two-year survival for black vs non black liver reCipi-
ents, 1981 through 1988. 
renal transplantation.4 However, a closer look at the black 
transplant constituency revealed a disquieting trend that 
suggested the difficulty of older blacks in gaining entry to the 
waiting list. 
This was a difficulty not encountered to the same degree by 
black pediatric recipients, who represented 13.9% of the 
pediatric cases. Most of these patients were treated after 
1983. Late in that year, a decision was made by Feder"l 
Medicare and announced by the Secretary of the Depart-
ment of Health, Education and Welfare (HEW) that liver 
transplantation was a service as opposed to an experimental 
operation but only for those who were 18 years old or 
younger. This meant that black infants and children could 
qualify for coverage under the Social Security system. More 
Table 2. Liver Diseases of Adult ReCipients, 1981-1988 
Disease Black Nonblack Total 
Cirrhosis (postnecrotic and 
cryptogenic) 18 
HB.Ag positive 3 
Alcoholic 5 
Primary biliary cirrhosis 4 
Primary sclerosing cholangitis 10 
Liver-based inborn metabolic er-
rors (a,-antitrypsin deficiency, 
Wilson's disease) 
Primary hepatic malignancy 4 
Fulminant hepatic failure 11 
Secondary biliary cirrhosis 
Budd-Chiari syndrome 
Bile duct cancer 
Secondary hepatic malignancy 
Others 
Total 
3 
60 
269 287 
61 64 
103 108 
203 207 
91 101 
50 51 
50 54 
37 48 
13 13 
18 19 
10 10 
8 8 
24 27 
937 997 
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Fig 4_ Two-year survival of black vs nonblack adults, 1981 
through 1988_ 
important, it strengthened their claim to other federal 
insurance programs, such as CHAMPUS, and on conven-
tional civilian health insurance carriers. 
Unfortunately, the Medicare ruling retained the terminol-
ogy of "experimental" if a liver transplantation candidate 
was older than 18 years. This administrative stigma has 
never been formally removed. The natural consequence has 
been that socially and economically underprivileged adults 
have been selectively denied life-saving health care. Black 
adults have been disproportionately affected. 
The extent of the injustice can be further illustrated by 
examining reports from the National Center For Health 
Statistics about chronic liver disease and cirrhosis.5 Liver 
disease was the ninth leading cause of death for all races in 
Table 3. Liver Diseases of Pediatric ReCipients, 1981-1988 
Disease Black Nonblack Total 
Biliary atresia 46 188 234 
Liver-based inborn metabolic er-
rors (a,-antitrypsin deficiency, 
Wilson's disease) 73 74 
Cirrhosis (postnecrotic and 
cryptogenic) 5 39 44 
Familial cholestatic syndrome 15 15 
Fulminant hepatic failure 3 20 23 
Secondary biliary cirrhosis 9 9 
Congenital hepatic fibrosis 6 6 
Primary hepatic malignancy 2 6 8 
Budd-Chiari syndrome 2 2 
Neonatal hepatitis 1 4 5 
Others 2 10 12 
Total 60 372 432 
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Fig 5_ Two-year pediatric liver transplant survival, black vs 
nonblack, 1981 through 1988. 
the United States in 1986. Black males had a death rate from 
liver disease of 17.3/100,000, whereas in white males, the 
figure was 14.1/100,000. Since the black population of the 
United States is 12.2% of the total, it would seem obvious 
that the percentage of adult liver recipients should be at least 
as high as non black recipients and probably even slightly 
greater. 
The point system is color blind. However, it ensures equi!y 
only after entry to the candidacy list. The naked prejudice 
implicit in our data is fiscal in nature.6 There is no medical 
justification for such a prejudice, since the overall results are 
equivalent in blacks and whites. The degraded results in 
adult blacks were most obvious perioperatively and may have 
reflected the more advanced disease that seemed common in 
this population. The poor results also could represent eco-
nomic and vocational hardships even after a successful 
transplantation. That there is no inherent biologic explana-
tion is evident from the superior results in black infants and 
children. 
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